Keywords: evidence, risk, abacavir, chmp, finalizing, review, recent

"No evidence" of risk with abacavir; CHMP

Article | 27 April 2009

Finalizing a review of recent data on the risk of myocardial infarction associated with the use of UK drug major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in